BioZen Limited 

Developing the world’s first approved medical cure for moobs!

OWNER

Ilan Chaitowitz (See Profile)


Sector

Biotech

Stage

Development, market readiness, clinical trial

Country

United Kingdom


First-in-class approved cure for gynecomastia that of all males and side-effect of androgen blockade for prostate cancer

Proven management team along with strategic partnership with Syneos Health who anticipate >$350m annual peak sales

Strong IP position covering both method of use and formulation - global rights and long duration

Compelling return profile - proof-of-concept scheduled to read out within three years

Low clinical risk using known molecules with synergistic MoA

Status

Pending

IP Type

Patent

Time

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Netherlands
Switzerland
USA
United Kingdom

Coverage

Method of use and formulation for gynecomastia.

Know more of this patent

Under evaluation at least till: 1st of October 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar